Blinatumomab (Blincyto)
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Blinatumomab (Blincyto), covering 2025-05-18 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia [Phase 3]